-
Vpliv statinov in fibratov na funkcionalne in morfološke lastnosti arterijske stene pri bolnikih s kombinirano hiperlipidemijo : [magistrso delo]Šebeštjen, MiranBackground: Endothelial dysfunction manifested by diminished flow-mediated dilation (FMD) of brachial artery has been shown to improve after treatment with several lipolytics in patients with ... hypercholesterolemia. However, there is no data of the effects of cerivastatin, new HMG-CoA reductase inhibitor andfibric acid derivate fenofibrate on the endothelial dysfunction in subjectswith combined hyperlipidemia. Subjects and methodsČ Forty middle-aged males with combined hyperlipidemia with no other atherogenic risk factors wererandomised, after 6 week run-in phase with AHA step I diet treatment, to 12 week treatment either with fenofibrate (250 mg daily) or cerivastatin. Cerivastatin was given in daily dose of 0,2 mg for 6 weeks and was increased to 0,4 mg daily in 10 patients, who did not achieve LDL-cholesterol goal of <3,0 mmol/I. At the beginning and every 6 weeks physical examination and anthropometric measurement were performed and blood total, LDL and HDL cholesterol, glucose, insulin, apolipoprotein A1, apolipoprotein B, lipoprotein (a), tissue type plasminogen activator (t-PA) antigen and activity, plasminogen activator inhibitor (PAI-1) antigen and activity, fibrinogen and euglobulin clot lysis time were detennined. We estimated the presence of small, dense LDL particles with relation LDL cholesterol/apolipoprotein B. Insulin resistance was calculated by using HOMA mathematical model. The endothelium-dependent and endothelium-independent dilation were calculated using the diameters of the brachial artery measured by high resolution ultrasound at rest, after reactive hyperemia and after sublingual glyceriltrinitrate. (Abstracts truncated at 2000 characters.)Vrsta gradiva - magistrsko deloZaložništvo in izdelava - Ljubljana : [M. Šebeštjen], 2000Jezik - slovenskiCOBISS.SI-ID - 2182420
Avtor
Šebeštjen, Miran
Drugi avtorji
Keber, Irena
Teme
Hyperlipidemia, familial combined |
Drug therapy |
Hydroxymethylglutaryl-coa reductase inhibitors |
Therapeutic use |
Procetofen |
Therapeutic use |
Vasodilatation |
Drug effects |
Brachial artery |
Drug effects |
Hiperlipidemiaja, družinska kombinirana |
Terapija z zdravili |
Inhibitorji hidroksimetilglutaril-coa reduktaze |
Terapevtska raba |
Procetofen |
Terapevtska raba |
Vazodilatacija |
Učinki zdravil |
Brahialna arterija |
Učinki zdravil |
Žilne bolezni |
metabolizem
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Knjižnica/institucija |
Kraj | Akronim | Za izposojo | Druga zaloga |
---|---|---|---|---|
MF, Centralna medicinska knjižnica, Ljubljana | Ljubljana | CMK |
na dom 1 izv.
|
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Šebeštjen, Miran | 19345 |
Keber, Irena | 00365 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.